2021
DOI: 10.1002/chir.23308
|View full text |Cite
|
Sign up to set email alerts
|

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)‐ibuprofen

Abstract: S(+)-ibuprofen (S-IBU) and R(−)-ibuprofen (R-IBU) concentrations were measured in 16 neonates with patent ductus arteriosus during a cycle of therapy (three intravenous doses of 10-5-5 mg kg −1 at 24-h intervals), at the end of the first infusion and 6, 24, 48, and 72 h later. Data were analyzed with a PK model that included enantiomer elimination rate constants and the R-to S-IBU conversion rate constant. The T½ of S-IBU in the newborn was much longer than in adults (41.8 vs. ≈2 h), whereas the T½ of R-IBU ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
(57 reference statements)
0
2
0
Order By: Relevance
“…One PK study in 108 neonates treated with IV ibuprofen reported a low systemic R- to S-conversion rate of 17% [10]. A second study in 16 neonates where ibuprofen was administered IV in a 10-5-5 mg/kg dose schedule found evidence for enantiomeric conversion with a mean rate of 41%, albeit with a wide range (7–87%) [20].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One PK study in 108 neonates treated with IV ibuprofen reported a low systemic R- to S-conversion rate of 17% [10]. A second study in 16 neonates where ibuprofen was administered IV in a 10-5-5 mg/kg dose schedule found evidence for enantiomeric conversion with a mean rate of 41%, albeit with a wide range (7–87%) [20].…”
Section: Discussionmentioning
confidence: 99%
“…However, the evidence on enantiomeric conversion in neonates is rather weak. While numerous studies report fractions of the dose undergoing enantiomeric conversion of around 60% in adults [16][17][18][19], conflicting results are reported for conversion in neonates with fractions varying from 0 to 61% [9][10][11]20].…”
Section: Introductionmentioning
confidence: 99%